pharmaceutical-technology.com

Tasks

Avoid using deprecated HTML tags.
Implement the viewport meta tag.

SEO

URL

Domain : www.pharmaceutical-technology.com/

Character length : 34

Title

Pharmaceutical Technology

Description

Pharmaceutical Technology is a procurement and reference site providing a one-stop-shop for professionals and decision makers within the global Pharmaceutical industry

Keywords (meta keywords)

Good! The website does not use “meta keywords”.

Open Graph Protocol

Error! The website does not use the OG (Open Graph) protocol.

Dublin Core

Dublin Core is in use

Underscores in the URLs

Error! Hyphen (-) is a better solution than underscore (_) in the URLs

http://www.pharmaceutical-technology.com/.. /aptar ("Suppliers")
http://www.pharmaceutical-technology.com/.. /aptar ("Setting the Standard for Drug Delivery")
http://www.pharmaceutical-technology.com/.. /systag ("SYSTAG, System Technik AG")
http://www.pharmaceutical-technology.com/.. /efficient-synthesis-development ("Efficient Synthesis Development")
http://www.pharmaceutical-technology.com/.. /lte-scientific ("LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry")
http://www.pharmaceutical-technology.com/.. /priorclave-autoclaves ("Priorclave - Autoclaves and Sterilisation Equipment")
http://www.pharmaceutical-technology.com/privacy_policy.html ("Privacy")
Expand

Search engine friendly URLs

Good! The website uses SEO friendly URLs.

Checking the robots.txt file

There is robots.txt file.
https://pharmaceutical-technology.com/robots.txt

User-agent	Disallowed for the search engines
*	/search /Search /WT.mc_id= /WT.MC_ID= /wt.mc_id= /wt.MC_ID=

Social

Social Engagement

Linkedin46

Facebook Share0

Facebook Comments0

Content

Doctype

HTML 5

Encoding

Perfect! The character encoding is set: UTF-8.

Language

Error! No language localization is found.

Title

Pharmaceutical Technology

Character length : 25

Good! The title’s length is between 10 and 70 characters.

Text / HTML ratio

Ratio : 20%

Acceptable! The text / code ratio is between 15 and 25 percent.

Headings

H1	H2	H3	H4	H5	H6
4	38	170	106	0	0

Heading structure in the source code

<H2> Drug Development
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Analysis
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H3> Analysis
<H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
<H3> Analysis
<H4> Challenging the link between pharma innovation and US drug pricing
<H2> Clinical Trials
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
<H3> Analysis
<H4> Challenging the link between pharma innovation and US drug pricing
<H3> Comments
<H4> PCR-based C. difficile Cytotoxin assays alone not appropriate for pivotal endpoint measures
<H3> Analysis
<H4> Cancergraph: a desperately needed link between patient and clinical trial
<H2> Manufacturing
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Analysis
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H3> Analysis
<H4> Crowdfunding for cancer therapy
<H3> Analysis
<H4> Pharmaceutical packaging: where should drug companies focus their efforts?
<H2> Packaging
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Pharmaceutical packaging: where should drug companies focus their efforts?
<H3> Suppliers
<H4> Aptar Pharma - Setting the Standard for Drug Delivery
<H3> Analysis
<H4> Taking the sting out of painkillers: how close are we to ending the opiate epidemic?
<H3> Analysis
<H4> Pharma Technology Focus – Issue 50
<H2> Cold Chain
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
<H3> Analysis
<H4> India's drug price overhaul: a question of balance
<H3> Analysis
<H4> Pfizer’s big antibiotic buyout: a sign of things to come?
<H3> Analysis
<H4> Taking the sting out of painkillers: how close are we to ending the opiate epidemic?
<H2> Diseases
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Crowdfunding for cancer therapy
<H3> Comments
<H4> More than just a pretty face: Botox set to combat depression
<H3> Comments
<H4> Curing hepatitis C: A double-edged sword for liver transplant candidates?
<H3> Comments
<H4> Small but mighty: nanotechnology in cancer therapy
<H2> Market Data
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Analysis
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H3> Analysis
<H4> Challenging the link between pharma innovation and US drug pricing
<H3> Analysis
<H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
<H2> Technology
<H3> Projects »
<H3> Analysis »
<H3> News »
<H3> Suppliers »
<H3> White Papers »
<H3> Videos »
<H3> Comment »
<H3> Research Reports »
<H3> Analysis
<H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
<H3> Analysis
<H4> Narrowing the hunt for nanoparticles
<H3> Comments
<H4> Small but mighty: nanotechnology in cancer therapy
<H3> Projects
<H4> Michael Uren Biomedical Engineering Research Hub, London
<H2> Companies
<H3> Company A-Z »
<H3> Products & Services »
<H3> Press Releases »
<H3> White Papers »
<H3> Videos »
<H3> Suppliers
<H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
<H3> Suppliers
<H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
<H3> Suppliers
<H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
<H3> Suppliers
<H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
<H2> All Sections
<H3> Projects »
<H3> Analysis »
<H3> Company A-Z »
<H3> Products & Services »
<H3> News »
<H3> Press Releases »
<H3> White Papers »
<H3> Comment »
<H3> Research Reports »
<H3> Advertise With Us »
<H3> Report Store »
<H3> About us »
<H2> Today's Top Stories
<H1> Are cheap Canadian drugs a solution to US pricing issues?
<H1> AGORA Cancer Centre, Lausanne
<H1> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H1> European Molecular Biology Laboratory Site, Barcelona
<H3> Headlines
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H4> AGORA Cancer Centre, Lausanne
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H4> European Molecular Biology Laboratory Site, Barcelona
<H2> Hot Topics
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H4> Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
<H4> Challenging the link between pharma innovation and US drug pricing
<H2> Comment & Analysis »
<H2> Aerie’s ophthalmic candidate succeeds in registration trial
<H2> Increased risk of amputation if taking type 2 diabetes drug Invokana
<H2> Transferring technology: from concept to commercialisation
<H2> Are cheap Canadian drugs a solution to US pricing issues?
<H2> New treatments will soon be available for long-neglected NASH sufferers
<H2> Company Releases »
<H2> Flexible, Accessible, Valuable, and Effective Imaging Solutions
<H2> Efficient Synthesis Development
<H2> Klocke uses NA and ML for Quality Storage
<H2> VeriPac UBV Universal Blister Verification
<H2> Child Safe Packaging Today
<H2> Pharmaceutical Insights »
<H3> Are cheap Canadian drugs a solution to US pricing issues?
<H3> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H3> Crowdfunding for cancer therapy
<H2> Pharmaceutical Industry Reports »
<H4> Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space
<H4> EMA set to approve plethora of oncology drugs
<H4> Oncology remains top orphan drug designation choice for companies after 5 years
<H4> Top indications and therapy areas for 2012-2016 clinical trials in Israel
<H2> Drug Development »
<H3> Suppliers
<H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
<H3> Comments
<H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Comments
<H4> New drug class set to reduce migraine misery
<H3> Comments
<H4> Pipeline biosimilar surge in emerging markets
<H3> Comments
<H4> Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’
<H2> Clinical Trials »
<H3> Suppliers
<H4> Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
<H3> Comments
<H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
<H3> Suppliers
<H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
<H3> Suppliers
<H4> Topstone Research - Clinical Trial Management
<H3> Comments
<H4> Transferring technology: from concept to commercialisation
<H3> Comments
<H4> New treatments will soon be available for long-neglected NASH sufferers
<H2> Manufacturing »
<H3> Suppliers
<H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
<H3> Suppliers
<H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
<H3> Suppliers
<H4> LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Suppliers
<H4> Priorclave - Autoclaves and Sterilisation Equipment
<H3> Suppliers
<H4> Quality Assurance Management (QAM) - Inspection and Analytical Services for the Pharmaceutical Industry
<H2> Packaging »
<H3> Suppliers
<H4> Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
<H3> Projects
<H4> AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
<H3> Suppliers
<H4> Skrivanek - Medeical and Pharmaceutical Translation Services for Packaging, Clinical Trials, and Regulatory Documentation
<H3> Suppliers
<H4> Lablabo - Airless Metering Pumps for the Pharmaceutical Industry
<H3> Projects
<H4> Biosciences Partnership Building, Phoenix
<H3> Analysis
<H4> Pharma Technology Focus – Issue 58
<H2> Cold Chain »
<H3> Suppliers
<H4> O&S Shipping - Freight Forwarding Solutions for Pharmaceuticals
<H3> Comments
<H4> Seikagaku inks deal with Ono Pharmaceutical, strengthening its position in the Osteoarthritis market
<H3> Analysis
<H4> Brain boosters: exploring the grey area of off-label ‘smart drugs’
<H3> Projects
<H4> AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
<H3> Suppliers
<H4> Lablabo - Airless Metering Pumps for the Pharmaceutical Industry
<H3> Suppliers
<H4> Munters - High-Quality Air Treatment Solutions for Pharma Production
<H2> Diseases »
<H3> Comments
<H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
<H3> Suppliers
<H4> Topstone Research - Clinical Trial Management
<H3> Projects
<H4> AGORA Cancer Centre, Lausanne
<H3> Comments
<H4> Roundup of Key Oncology Strategic Alliances in Q1 2017
<H3> Comments
<H4> New drug class set to reduce migraine misery
<H3> Comments
<H4> Highlights from the 2017 ATS Conference
<H2> Market Data »
<H3> Comments
<H4> Increased risk of amputation if taking type 2 diabetes drug Invokana
<H3> Analysis
<H4> Are cheap Canadian drugs a solution to US pricing issues?
<H3> Comments
<H4> Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations
<H3> Comments
<H4> Pacific Biosciences: don’t count them out yet
<H3> Analysis
<H4> BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
<H3> Analysis
<H4> Challenging the link between pharma innovation and US drug pricing
<H2> Technology »
<H3> Suppliers
<H4> TechTrak - Contaminant Control Flooring for Cleanroom Environments
<H3> Suppliers
<H4> Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
<H3> Comments
<H4> Transferring technology: from concept to commercialisation
<H3> Suppliers
<H4> LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry
<H3> Comments
<H4> New treatments will soon be available for long-neglected NASH sufferers
<H3> Suppliers
<H4> O&S Shipping - Freight Forwarding Solutions for Pharmaceuticals
<H2> Follow Us
<H2> Newsletter
<H2> Latest News »
<H4> Deals this week: Inthera Bioscience, i2 Pharmaceuticals, InventisBio
<H4> M&As this week: Inspyr Therapeutics, Nissui Pharmaceutical
<H4> Chiltern buys IDA to integrate Japan and Asia into global drug development
<H4> Pfizer receives EC approval for Trumenba to prevent MenB disease in adolescents and young adults
<H4> Report shows research collaboration between UK and EU strengthens medical co-operation
<H2> Companies »
<H4> Cellular Technology Limited (CTL)
<H4> Plastiape Group
<H4> Topstone Research
<H4> TechTrak
<H4> Molnár-Institute
<H3> Follow us:

Word cloud

drug45
analysis44
suppliers34
pharmaceutical32
pricing30
clinical27
industry25
trial24
drugs23
comments22
issues20
solution20
canadian19
cheap19
new18
technology18
pharma18
packaging17
projects17
stem16
bluerock16
research16
cell15
contender15
petri15
dish15
journey15
canada’s15
cancer15
news13
therapy13
between13
solutions12
link12
development11
papers11
white11
innovation10
taking10
services10
delivery10
challenging10
reports10
comment10
videos10
companies9
disease9
risk9
medical9
possibilities8
laboratory8
detection8
focus8
set8
nanotech8
offers8
micro-machines8
oncology7
centre7
crowdfunding7

Keyword matrix

word	title	descriptions	heading
drug
analysis
suppliers
pharmaceutical
pricing
clinical

Two Word cloud

stem cell11
pharmaceutical industry11
cheap canadian11
canadian drugs10
pricing issues9
canada’s stem9

Three Word cloud

journey from petri15
are cheap canadian11
canada’s stem cell9
stem cell contender6
link between pharma6
clinical trial analysis5

404 Page

The website has a 404 error page.

Flash content

Good! The website does not have any flash contents.

Frame

Good! The website does not use iFrame solutions.

Images

We found 37 images on this web page.

Alternate attributes for the following 36 images are missing. Search engines use "alt" tags to understand image content efficiently. We strongly recommend fixing this issue.

Technologies

Mobile optimization

This website is optimal for mobile devices!

Deprecated HTML elements

Good! No deprecated HTML tags are detected.

Redirection (www / not www)

Good! The web address is accessible only in one version. The version without www is redirected to the version with www.

Deprecated HTML elements

Good! No deprecated HTML tags are detected.

Printability

Good! The website uses printer-friendly CSS.

Meta Tag (viewport tag, mobile devices)

Error! The meta tag named viewport is missing.

Speed test

Server response time

The server response time is fast enough.

Loading time

4,395 ms

Table layout

Good! No nested tables found.

Render blocking resources

Good! No render blocking elements found!

Speed test – Javascript

Javascript

Error! Too many javascript files found which slows down the page load on the website.

http://www.pharmaceutical-technology.com/scripts/jquery-1.4.1.min.js
http://www.pharmaceutical-technology.com/content/jquery/jquery.tools.min.js
http://www.pharmaceutical-technology.com/scripts/jquery.validate.js
http://www.pharmaceutical-technology.com/scripts/xval.jquery.validate.js
http://www.pharmaceutical-technology.com/scripts/pmg.customvalidators.js
http://www.pharmaceutical-technology.com/content/jquery/jquery.jalert.js
http://www.pharmaceutical-technology.com/content/js/kgi-master-head.min.js
http://www.pharmaceutical-technology.com/content/scripts/slick/slick.min.js
http://www.pharmaceutical-technology.com/scripts/pharmaceutical.sdc.js
http://www.pharmaceutical-technology.com/content/js/kgi-master.min.js

File size of all javascript files combined

0.00

Javascript minifying

Great! The Javascript files are minified.

Speed test – CSS

CSS

Error! Too many CSS files detected that slows down the page load.

http://www.pharmaceutical-technology.com/content/font-awesome.css
http://www.pharmaceutical-technology.com/content/final_css_print.min.css
http://www.pharmaceutical-technology.com/content/css/jquery_ui_datepicker.css
http://www.pharmaceutical-technology.com/content/css/jalert.css
http://www.pharmaceutical-technology.com/content/kgi-master.min.css
http://www.pharmaceutical-technology.com/content/technology-theme.min.css

File size of all css files combined

0.00

CSS minifying

Great! The CSS elements are minified.

Speed test – Compression

Uncompressed size of the of the HTML

0.00

Gzip compression

Your site uses compression.

Speed test – Browser cache

Browser cache

The browser cache is set correctly for all elements.

Speed test – Images

File size of all images combined

0.00

Image optimisation

All images are optimized.

Traffic

Alexa

409320

Links

We found a total of 239 different links.
Internal links: 230
External links: 9

External links:

Link text (anchor)	Link strength
Log in
Register
Report Store »
Facebook
Twitter
Advertise with us
Digital Magazine
http://www.facebook.com/.. /192069854235750
https://twitter.com/#!/PharmTechnology

Internal links:

Link text (anchor)	Link strength
Pharmaceutical Technology
Advertise With Us
Drug Development
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Analysis
Are cheap Canadian drugs a solution to US pricing issues?
Analysis
BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial
Analysis
Micro-machines: nanotech offers new possibilities for disease detection and drug delivery
Analysis
Challenging the link between pharma innovation and US drug pricing
Clinical Trials
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Comments
PCR-based C. difficile Cytotoxin assays alone not appropriate for pivotal endpoint measures
Analysis
Cancergraph: a desperately needed link between patient and clinical trial
Manufacturing
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Analysis
Crowdfunding for cancer therapy
Analysis
Pharmaceutical packaging: where should drug companies focus their efforts?
Packaging
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Suppliers
Setting the Standard for Drug Delivery
Analysis
Taking the sting out of painkillers: how close are we to ending the opiate epidemic?
Analysis
Pharma Technology Focus – Issue 50
Cold Chain
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Analysis
Brain boosters: exploring the grey area of off-label ‘smart drugs’
Analysis
India's drug price overhaul: a question of balance
Analysis
Pfizer’s big antibiotic buyout: a sign of things to come?
Diseases
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Comments
More than just a pretty face: Botox set to combat depression
Comments
Curing hepatitis C: A double-edged sword for liver transplant candidates?
Comments
Small but mighty: nanotechnology in cancer therapy
Market Data
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Technology
Projects »
Analysis »
News »
Suppliers »
White Papers »
Videos »
Comment »
Research Reports »
Analysis
Narrowing the hunt for nanoparticles
Projects
Michael Uren Biomedical Engineering Research Hub, London
Companies
Company A-Z »
Products & Services »
Press Releases »
White Papers »
Videos »
Suppliers
Contact Laboratory Services Provider
Suppliers
Medical Devices and Packaging Solutions for the Pharmaceutical Industry
Suppliers
Contaminant Control Flooring for Cleanroom Environments
Suppliers
HPLC Method Development Software for the Pharmaceutical Industry
Videos
Events
Projects »
Analysis »
News »
White Papers »
Comment »
Research Reports »
Advertise With Us »
About us »
AGORA Cancer Centre, Lausanne
European Molecular Biology Laboratory Site, Barcelona
Comment & Analysis »
GlobalData Healthcare
Aerie’s ophthalmic candidate succeeds in registration trial
Increased risk of amputation if taking type 2 diabetes drug Invokana
Transferring technology: from concept to commercialisation
New treatments will soon be available for long-neglected NASH sufferers
Company Releases »
ASPYRA
Flexible, Accessible, Valuable, and Effective Imaging Solutions
SYSTAG, System Technik AG
Efficient Synthesis Development
http://www.pharmaceutical-technology.com/article-feature.html
Munters
Klocke uses NA and ML for Quality Storage
PTI - Packaging Inspection Systems
VeriPac UBV Universal Blister Verification
Origin Pharma Packaging
Child Safe Packaging Today
Pharmaceutical Industry Reports »
Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space
EMA set to approve plethora of oncology drugs
Oncology remains top orphan drug designation choice for companies after 5 years
Top indications and therapy areas for 2012-2016 clinical trials in Israel
Drug Development »
Suppliers
Cellular Technology Limited (CTL) - Contact Laboratory Services Provider
Comments
Analysis
New drug class set to reduce migraine misery
Pipeline biosimilar surge in emerging markets
Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’
Clinical Trials »
Suppliers
Comments
Molnár-Institute - HPLC Method Development Software for the Pharmaceutical Industry
Topstone Research - Clinical Trial Management
Manufacturing »
Suppliers
Plastiape Group - Medical Devices and Packaging Solutions for the Pharmaceutical Industry
TechTrak - Contaminant Control Flooring for Cleanroom Environments
LTE Scientific - Autoclaves and Thermal Equipment for the Medical Industry
Analysis
Priorclave - Autoclaves and Sterilisation Equipment
Quality Assurance Management (QAM) - Inspection and Analytical Services for the Pharmaceutical Industry
Packaging »
Suppliers
Projects
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge
Skrivanek - Medeical and Pharmaceutical Translation Services for Packaging, Clinical Trials, and Regulatory Documentation
Lablabo - Airless Metering Pumps for the Pharmaceutical Industry
Biosciences Partnership Building, Phoenix
Analysis
Pharma Technology Focus – Issue 58
Cold Chain »
Suppliers
O&S Shipping - Freight Forwarding Solutions for Pharmaceuticals
Comments
Seikagaku inks deal with Ono Pharmaceutical, strengthening its position in the Osteoarthritis market
Analysis
Projects
Munters - High-Quality Air Treatment Solutions for Pharma Production
Diseases »
Comments
Suppliers
Projects
Roundup of Key Oncology Strategic Alliances in Q1 2017
Highlights from the 2017 ATS Conference
Market Data »
Comments
Analysis
Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations
Pacific Biosciences: don’t count them out yet
Technology »
Suppliers
Comments
Deals this week: Inthera Bioscience, i2 Pharmaceuticals, InventisBio Jun 02
M&As this week: Inspyr Therapeutics, Nissui Pharmaceutical Jun 02
Chiltern buys IDA to integrate Japan and Asia into global drug development Jun 01
Pfizer receives EC approval for Trumenba to prevent MenB disease in adolescents and young adults Jun 01
Report shows research collaboration between UK and EU strengthens medical co-operation Jun 01
Cellular Technology Limited (CTL) Contact Laboratory Services Provider
Plastiape Group Medical Devices and Packaging Solutions for the Pharmaceutical Industry
Topstone Research Clinical Trial Management
TechTrak Contaminant Control Flooring for Cleanroom Environments
Molnár-Institute HPLC Method Development Software for the Pharmaceutical Industry
http://www.pharmaceutical-technology.com
Contact us
Terms and conditions
Privacy
Links
About us
Copyright

Website security

217.147.67.97

External hidden links

Good! No hidden external links found

Looking for eval()

Good! No eval(bas64_decode()) scripts are found

Checking for XSS vulnerability

No XSS vulnerability found

Email encryption

Good! We have not found any unencrypted email addresses.

Sites on same ip

chemicals-technology.com

hydrocarbons-technology.com

the-financedirector.com

banking-gateway.com

medicaldevice-network.com

hospitalmanagement.net

foodprocessing-technology.com

airforce-technology.com

railway-technology.com

Icons

Favicon

Good! The website uses favicon.

Order of Heading elements on mobile by position

H2 : Drug Development, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Counting the cost of failure in drug development, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
H2 : Clinical Trials, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Counting the cost of failure in drug development, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
H2 : Manufacturing, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Are cheap Canadian drugs a solution to US pricing issues?, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Crowdfunding for cancer therapy, ( 0px from top )
H3 : Projects, ( 0px from top )
H4 : Michael Uren Biomedical Engineering Research Hub, London, ( 0px from top )
H2 : Packaging, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Pharmaceutical packaging: where should drug companies focus their efforts?, ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Aptar Pharma - Setting the Standard for Drug Delivery, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Taking the sting out of painkillers: how close are we to ending the opiate epidemic?, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Pharma Technology Focus – Issue 50, ( 0px from top )
H2 : Cold Chain, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Brain boosters: exploring the grey area of off-label ‘smart drugs’, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : India's drug price overhaul: a question of balance, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Pfizer’s big antibiotic buyout: a sign of things to come?, ( 0px from top )
H2 : Diseases, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer, ( 0px from top )
H2 : Market Data, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Loss of exclusivity to limit J&J gain after Zytiga label extension, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Chemo-free triplet regimens on the horizon for CLL, ( 0px from top )
H3 : Comments, ( 0px from top )
H4 : Poor tolerability of Opdivo + Yervoy in frontline NSCLC could be Achilles heel, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Pooling resources for clinical trials, ( 0px from top )
H2 : Technology, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Suppliers », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Counting the cost of failure in drug development, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Micro-machines: nanotech offers new possibilities for disease detection and drug delivery, ( 0px from top )
H3 : Analysis, ( 0px from top )
H4 : Narrowing the hunt for nanoparticles, ( 0px from top )
H2 : Companies, ( 0px from top )
H3 : Company A-Z », ( 0px from top )
H3 : Products & Services », ( 0px from top )
H3 : Press Releases », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Videos », ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Lablabo - Airless Metering Pumps for the Pharmaceutical Industry, ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Labworks International Inc. - Environment Controlled Rooms, Cleanrooms, ICH Stability Chambers, Freezers, and Coolers for Temperature-Sensitive Pharmaceutical and Medical Products, ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : Reliability and Maintenance Services Ltd - ISO17025 Accredited Calibration Services for Temperature, Humidity, and Pressure Instrumentation, ( 0px from top )
H3 : Suppliers, ( 0px from top )
H4 : tricumed Medizintechnik - Implantable Infusion Pumps to Treat Spasticity and Chronic Pain, ( 0px from top )
H2 : All Sections, ( 0px from top )
H3 : Projects », ( 0px from top )
H3 : Analysis », ( 0px from top )
H3 : Company A-Z », ( 0px from top )
H3 : Products & Services », ( 0px from top )
H3 : News », ( 0px from top )
H3 : Press Releases », ( 0px from top )
H3 : White Papers », ( 0px from top )
H3 : Comment », ( 0px from top )
H3 : Research Reports », ( 0px from top )
H3 : Advertise With Us », ( 0px from top )
H3 : Report Store », ( 0px from top )
H3 : About us », ( 0px from top )
H3 : Headlines, ( 0px from top )
H4 : Pharma Technology Focus – Issue 60, ( 0px from top )
H4 : Counting the cost of failure in drug development, ( 0px from top )
H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 0px from top )
H4 : Boehringer Ingelheim China Biopharmaceuticals Project, Shanghai, ( 0px from top )
H2 : Pharmaceutical Insights », ( 0px from top )
H3 : Pooling resources for clinical trials, ( 0px from top )
H3 : Are cheap Canadian drugs a solution to US pricing issues?, ( 0px from top )
H3 : BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial, ( 0px from top )
H2 : Pharmaceutical Industry Reports », ( 0px from top )
H4 : Glioblastoma: could Zika virus offer new treatment options?, ( 0px from top )
H4 : Diagnosed incident cases of cystic fibrosis are set to decrease, ( 0px from top )
H4 : China and infectious disease: the one to watch?, ( 0px from top )
H4 : Report: Chronic obstructive pulmonary disease market to reach $14.1bn by 2025, ( 0px from top )
H2 : Today's Top Stories, ( 156px from top )
H1 : Pharma Technology Focus – Issue 60, ( 374px from top )
H1 : Counting the cost of failure in drug development, ( 498px from top )
H1 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 614px from top )
H1 : Boehringer Ingelheim China Biopharmaceuticals Project, Shanghai, ( 784px from top )
H2 : Hot Topics, ( 938px from top )
H4 : Counting the cost of failure in drug development, ( 997px from top )
H4 : Could a temperature-resistant vaccine spell the end for rabies and yellow fever?, ( 1079px from top )
H4 : Pooling resources for clinical trials, ( 1182px from top )
H4 : Are cheap Canadian drugs a solution to US pricing issues?, ( 1243px from top )
H2 : Comment & Analysis », ( 1335px from top )
H2 : Pharma Technology Focus – Issue 60, ( 1401px from top )

Typos

harmaceutical-technology.com, poharmaceutical-technology.com, oharmaceutical-technology.com, plharmaceutical-technology.com, lharmaceutical-technology.com, p0harmaceutical-technology.com, 0harmaceutical-technology.com, p-harmaceutical-technology.com, -harmaceutical-technology.com, pharmaceutical-technology.com, harmaceutical-technology.com, p_harmaceutical-technology.com, _harmaceutical-technology.com, parmaceutical-technology.com, phbarmaceutical-technology.com, pbarmaceutical-technology.com, phgarmaceutical-technology.com, pgarmaceutical-technology.com, phtarmaceutical-technology.com, ptarmaceutical-technology.com, phyarmaceutical-technology.com, pyarmaceutical-technology.com, phuarmaceutical-technology.com, puarmaceutical-technology.com, phjarmaceutical-technology.com, pjarmaceutical-technology.com, phmarmaceutical-technology.com, pmarmaceutical-technology.com, phnarmaceutical-technology.com, pnarmaceutical-technology.com, phrmaceutical-technology.com, phaqrmaceutical-technology.com, phqrmaceutical-technology.com, phawrmaceutical-technology.com, phwrmaceutical-technology.com, phazrmaceutical-technology.com, phzrmaceutical-technology.com, pharmaceutical-technology.com, phrmaceutical-technology.com, phaxrmaceutical-technology.com, phxrmaceutical-technology.com, phasrmaceutical-technology.com, phsrmaceutical-technology.com, phamaceutical-technology.com, pharemaceutical-technology.com, phaemaceutical-technology.com, phardmaceutical-technology.com, phadmaceutical-technology.com, pharfmaceutical-technology.com, phafmaceutical-technology.com, phargmaceutical-technology.com, phagmaceutical-technology.com, phar4,maceutical-technology.com, pha4,maceutical-technology.com, phartmaceutical-technology.com, phatmaceutical-technology.com, phar5maceutical-technology.com, pha5maceutical-technology.com, pharaceutical-technology.com, pharmnaceutical-technology.com, pharnaceutical-technology.com, pharmhaceutical-technology.com, pharhaceutical-technology.com, pharmaceutical-technology.com, pharaceutical-technology.com, pharmjaceutical-technology.com, pharjaceutical-technology.com, pharmkaceutical-technology.com, pharkaceutical-technology.com, pharmlaceutical-technology.com, pharlaceutical-technology.com, pharm aceutical-technology.com, phar aceutical-technology.com, pharmceutical-technology.com, pharmaqceutical-technology.com, pharmqceutical-technology.com, pharmawceutical-technology.com, pharmwceutical-technology.com, pharmazceutical-technology.com, pharmzceutical-technology.com, pharmaceutical-technology.com, pharmceutical-technology.com, pharmaxceutical-technology.com, pharmxceutical-technology.com, pharmasceutical-technology.com, pharmsceutical-technology.com, pharmaeutical-technology.com, pharmacxeutical-technology.com, pharmaxeutical-technology.com, pharmacseutical-technology.com, pharmaseutical-technology.com, pharmaceutical-technology.com, pharmaeutical-technology.com, pharmacdeutical-technology.com, pharmadeutical-technology.com, pharmacfeutical-technology.com, pharmafeutical-technology.com, pharmacveutical-technology.com, pharmaveutical-technology.com, pharmac eutical-technology.com, pharma eutical-technology.com, pharmacutical-technology.com, pharmacewutical-technology.com, pharmacwutical-technology.com, pharmacesutical-technology.com, pharmacsutical-technology.com, pharmaceutical-technology.com, pharmacutical-technology.com, pharmacedutical-technology.com, pharmacdutical-technology.com, pharmacefutical-technology.com, pharmacfutical-technology.com, pharmacerutical-technology.com, pharmacrutical-technology.com, pharmace3utical-technology.com, pharmac3utical-technology.com, pharmace4utical-technology.com, pharmac4utical-technology.com, pharmacetical-technology.com, pharmaceuytical-technology.com, pharmaceytical-technology.com, pharmaceuhtical-technology.com, pharmacehtical-technology.com, pharmaceujtical-technology.com, pharmacejtical-technology.com, pharmaceuktical-technology.com, pharmacektical-technology.com, pharmaceuitical-technology.com, pharmaceitical-technology.com, pharmaceu7tical-technology.com, pharmace7tical-technology.com, pharmaceu8tical-technology.com, pharmace8tical-technology.com, pharmaceuical-technology.com, pharmaceutrical-technology.com, pharmaceurical-technology.com, pharmaceutfical-technology.com, pharmaceufical-technology.com, pharmaceutgical-technology.com, pharmaceugical-technology.com, pharmaceuthical-technology.com, pharmaceuhical-technology.com, pharmaceutyical-technology.com, pharmaceuyical-technology.com, pharmaceut5ical-technology.com, pharmaceu5ical-technology.com, pharmaceut6ical-technology.com, pharmaceu6ical-technology.com, pharmaceutcal-technology.com, pharmaceutiucal-technology.com, pharmaceutucal-technology.com, pharmaceutijcal-technology.com, pharmaceutjcal-technology.com, pharmaceutical-technology.com, pharmaceutcal-technology.com, pharmaceutilcal-technology.com, pharmaceutlcal-technology.com, pharmaceutiocal-technology.com, pharmaceutocal-technology.com, pharmaceuti8cal-technology.com, pharmaceut8cal-technology.com, pharmaceuti9cal-technology.com, pharmaceut9cal-technology.com, pharmaceuti*cal-technology.com, pharmaceut*cal-technology.com

More Sites

midnightadventure.net

Title: Midnight Adventure | การผจญภัยยามค่ำคืน
Description:
Internet Protocol (IP) address:
Tech:
- CMS
  - Wordpress CMS
- Analytic
  - Google Analytics
- Social
  - Facebook Like box
- Other
  - CSS (Cascading Style Sheets)
  - Flexslider
  - Google Font API
  - Html (HyperText Markup Language)
  - Html5
  - Iframe
  - Javascript
  - jQuery
  - jQuery Hover Intent
  - Php (Hypertext Preprocessor)
  - Pingback
  - Shortcodes
  - SuperFish

sohanthejeweller.com

Title: || SohantheJeweller.com ||
Description: Jeweller, Jeweller in Rajkot Gujarat India, Jewellery, sohan ornaments,designing Jeweller India
Sites loading time: 23866
Internet Protocol (IP) address:
Javascript total size: 78.81KB
CSS total size: 2.56KB
Image total size: 344.11KB
Total size: 448.43KB
Tech:
- Other
  - CSS (Cascading Style Sheets)
  - Html (HyperText Markup Language)
  - Iframe
  - Javascript

jamanagement.co.uk

Title: JA Management - London Property Managers - London Flat Rental
Description: JA Management - London Property Managers - London Flat Rental
Internet Protocol (IP) address:
Tech:
- Other
  - CSS (Cascading Style Sheets)
  - Html (HyperText Markup Language)
  - Javascript

yogalifestyle.us

Title: Yoga Lifestyle – Share your Story with us
Description:
Internet Protocol (IP) address:
Tech:
- CMS
  - Wordpress CMS
- Analytic
  - Google Analytics
- Other
  - CSS (Cascading Style Sheets)
  - Font Awesome
  - Html (HyperText Markup Language)
  - Html5
  - Javascript
  - jQuery
  - Modernizr.js
  - Php (Hypertext Preprocessor)
  - Pingback
  - SVG (Scalable Vector Graphics)

fastwayship.net

Title: FastWay Couriers | Fast-Secure-Service
Description:
Sites loading time: 7721
Internet Protocol (IP) address:
Javascript total size: 283.69KB
CSS total size: 75.82KB
Image total size: 356.85KB
Total size: 782.53KB
Tech:
- Other
  - CSS (Cascading Style Sheets)
  - Google Font API
  - Html (HyperText Markup Language)
  - Html5
  - Javascript
  - jQuery Fancybox
  - jQuery Validate
  - jQuery UI
  - PageSpeed Module
  - Php (Hypertext Preprocessor)
  - SVG (Scalable Vector Graphics)

nutritionmadesimple.org

Title: Nutrition Made Simple
Description:
Internet Protocol (IP) address:
Tech:
- Analytic
  - Google Analytics
- CDN
  - CloudFront
- Other
  - CSS (Cascading Style Sheets)
  - Html (HyperText Markup Language)
  - Html5
  - Javascript
  - SVG (Scalable Vector Graphics)

alliedhealthcareschool.com

Title:
Description:
Internet Protocol (IP) address:
Tech:
- Analytic
  - Google Analytics
- Other
  - CSS (Cascading Style Sheets)
  - Google Font API
  - Html (HyperText Markup Language)
  - Html5
  - Javascript

lorettabuyshousescash.com

Title: Sell Your House Today
Description: We buy houses in Milwaukee and close quickly. Want a fast cash offer for your house? Sell a house fast, any condition, any area.
Internet Protocol (IP) address:
Tech:
- Analytic
  - Google Analytics
- CDN
  - BootstrapCDN
- Other
  - CSS (Cascading Style Sheets)
  - Font Awesome
  - Html (HyperText Markup Language)
  - Iframe
  - Javascript
  - jQuery
  - Php (Hypertext Preprocessor)

networkcoffee.com

Title: Welcome To
Description:
Internet Protocol (IP) address:
Tech:
- Other
  - Html (HyperText Markup Language)

mamalifestyle.nl

Title: mamalifestyle.nl - Online magazine over mamalifestyle, alles voor de hippe mama
Description: Online magazine over mamalifestyle, alles voor de hippe mama
Internet Protocol (IP) address:
Tech:
- CMS
  - Wordpress CMS
- Analytic
  - Google Analytics
  - WordPress Stats
- Social
  - Facebook Box
  - Twitter Button
- Other
  - CSS (Cascading Style Sheets)
  - Font Awesome
  - Google Font API
  - Html (HyperText Markup Language)
  - Html5
  - Javascript
  - jQuery
  - Php (Hypertext Preprocessor)
  - Pingback

SEO report of pharmaceutical-technology.com